| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Gross Profit | $23K | — | — |
| R&D Expense | $703 | — | — |
| SG&A Expense | $68K | -91.0% | -78.5% |
| Operating Income | -$75K | +90.1% | +76.3% |
| Pre-tax Income | -$106K | +86.1% | +67.7% |
| Net Income | -$106K | +86.1% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $102K | +9127.8% | — |
| Accounts Receivable | $30K | — | -15.2% |
| Current Assets | $147K | +223.5% | +140.8% |
| Total Assets | $680K | +16.4% | -23.4% |
| Current Liabilities | $1.7M | +8.3% | +65.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$326K | — | — |
| Investing Cash Flow | -$22K | — | — |
| Financing Cash Flow | $428K | — | — |
| +67.7% |
| EPS (Basic) | $0.00 | +100.0% | — |
| EPS (Diluted) | $0.00 | +100.0% | — |
| $1.8M |
| +7.6% |
| +56.6% |
| Stockholders' Equity | -$1.1M | -2.9% | -316.3% |